Multicenter Automatic Defibrillator Implantation Trial With Cardiac Resynchronization Therapy (MADIT-CRT) Post Approval Registry
Status: | Completed |
---|---|
Conditions: | Cardiology |
Therapuetic Areas: | Cardiology / Vascular Diseases |
Healthy: | No |
Age Range: | 21 - Any |
Updated: | 5/27/2013 |
Start Date: | March 2011 |
End Date: | December 2013 |
Contact: | Arthur J Moss, MD |
Email: | heartajm@heart.rochester.edu |
Phone: | 585-275-5391 |
Multicenter Automatic Defibrillator Implantation Trial With Cardiac Resynchronization Therapy Post Approval Registry
MADIT-CRT PAR is an FDA mandated follow-up registry for patients that participated in the
MADIT-CRT IDE study examining long-term mortality.
The registry is designed to determine the long-term mortality benefit as a result of Cardiac
Resynchronization Therapy with Defibrillation (CRT-D) vs. Implantable Cardioverter
Defibrillator (ICD) therapy in the MADIT-CRT study patient population. The registry will
collect data on patients that previously participated at MADIT-CRT sites within the US
through five years of participation from their orginal enrollment in the MADIT-CRT IDE
study.
Inclusion Criteria:
- Active patients who were enrolled in the MADIT-CRT IDE within the United States
Exclusion Criteria:
- Patients who are unable or unwilling to comply with the protocol requirements
We found this trial at
1
site
Click here to add this to my saved trials